Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lam Research Corporation (LRCX) vs iShares MSCI China ETF (MCHI) Price & Performance

Lam Research CorporationTrade
iShares MSCI China ETFTrade

Price performance (Past 24H)

Key statistics

Lam Research Corporation vs iShares MSCI China ETF — how do they compare? Lam Research Corporation trades at $326.29 (market cap $389.67B), while iShares MSCI China ETF trades at $55.08. The key difference: Lam Research Corporation pays a 0.33% dividend while iShares MSCI China ETF pays none, and Lam Research Corporation is trading nearer its 52-week high, iShares MSCI China ETF nearer its low. Which is the better fit depends on your goals.

LRCXMCHI
Market Cap
$389.67B
Sector
TechnologyBroad Market / Factor
52-Week High
$433.33$66.99
52-Week Low
$97.03$50.48
Enterprise Value
$387.83B
Dividend Yield
0.33%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lam Research Corporation

Lam Research (LRCX) trades at $326.02, up 6.4% in 24 hours, with a bullish technical signal and strong earnings beats. The stock shows robust fundamentals with a 29.06% net income margin and 65.07% ROE in 2025, supported by positive analyst sentiment and expansion into panel-level packaging. Recent news highlights AI-driven semiconductor demand as a key growth catalyst.

Outlook remains positive given consensus price target of $397.18 and 78% buy ratings, though high P/E of 54.06 and competitive pressures from new entrants like SpaceX's Terrafab pose risks. Revenue growth to $23.2B in 2026 suggests sustained momentum, but investors should monitor execution amid industry volatility.

iShares MSCI China ETF

MCHI trades at $55.01, down 3.37% amid broader Chinese stock pressure. Technical indicators show a bullish overall signal with strong moving average support, though oscillators remain neutral. The ETF benefits from China's export strength and AI-driven manufacturing rebound, with exports jumping 23% in July (CNBC, 2026-08-06). Recent institutional activity includes Empowered Funds acquiring $1.47M in shares (Defense World, 2026-08-08).

MCHI presents value opportunity trading at significant discount to US indices, with financial sector benefiting from China's yield curve. Key risks include US-China trade tensions and regulatory uncertainty. The $295B AI infrastructure plan (Bloomberg, 2026-06-09) provides long-term growth catalyst, though near-term volatility persists amid geopolitical headwinds.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Lam Research Corporation

Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.

Read more on LRCX

About iShares MSCI China ETF

MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.

Read more on MCHI